Content about Medicine

March 7, 2010
Bristol-Myers Squibb, Isis announce partnership for cholesterol drug

Bristol-Myers Squibb has paid Isis Pharmaceuticals a $6 million milestone payment for regulatory approval to...

March 7, 2010
Clinical study: Pfizer-Bristol anticoagulant more effective than competitior

A pill-based anticoagulant drug under development by Pfizer and Bristol-Myers Squibb worked better in reducing...

March 7, 2010
Divine Mercy Care Pharmacy closes in D.C. area

The only pro-life pharmacy in the metropolitan area of the nation’s capital is closing, according...

March 7, 2010
Genzyme, PTC: Mid-stage trial for DBMD treatment yields mixed results

A mid-stage clinical trial of a drug for muscular dystrophy got mixed results, developers Genzyme...

March 7, 2010
Roche, Biogen Idec halt ocrelizumab trials

Roche and Biogen Idec are suspending trials of a drug for treating autoimmune disorders amid...

March 7, 2010
Study: Dementia may be triggered by depression in diabetics

Diabetic adults with depression are twice as likely to develop dementia, according to a new...

March 7, 2010
Taro receives FDA approval for skin cancer generic

The Food and Drug Administration has approved Taro Pharmaceutical Industries’ generic version of a drug...

March 4, 2010
Acorda announces availability of MS treatment

A new drug by Acorda Therapeutics for treating multiple sclerosis has become available, Acorda announced....

March 4, 2010
Biosimilars could bring down specialty drug spending

If Medicare Part D is to remain solvent in the future, then lawmakers may want...

WHAT IT MEANS AND WHY IT'S IMPORTANT If Medicare Part D is to remain solvent in the future, then lawmakers may want to take a closer look at the more than 10% of spending on drugs under the program that has gone toward specialty drugs — some of the most expensive drugs on the market — and find ways to come up with cheaper alternatives.

March 4, 2010
CVS partnership may drive down healthcare costs

CVS Caremark’s Behavior Change Research Partnership with several leading universities is likely to yield some...

WHAT IT MEANS AND WHY IT'S IMPORTANT CVS Caremark’s Behavior Change Research Partnership with several leading universities is likely to yield some invaluable results for the industry at large because if CVS Caremark executives and the participating academic leaders can better understand customer behavior and develop ways to encourage improved healthy behaviors, then the end result likely will be lower healthcare costs.

March 4, 2010
FDA reviewing InterMune's IPF drug

The Food and Drug Administration is reviewing a drug for treating a lung condition that...

March 4, 2010
NACDS' policy recommendations for medication adherence featured in journal

The National Association of Chain Drug Stores’ campaign to raise awareness of pharmacy’s role in...

March 4, 2010
OrbiMed Advisors: Astellas should raise bid for OSI

One of the biggest holders of OSI Pharmaceuticals’ stock has said Japanese drug maker Astellas...

March 4, 2010
Take Care to implement Greenway's PrimeSuite in worksite health centers

Greenway Medical Technologies, a provider of electronic health records, ambulatory health care and clinical research...

CARROLLTON, Ga. Greenway Medical Technologies, a provider of electronic health records, ambulatory health care and clinical research business solutions and services, will supply its integrated EHR and interoperability solution to Take Care Health Employer Solutions, which builds and operates workplace-based health centers.

March 4, 2010
TechWorld Medicals product best in show at ECRM Cough & Cold and Allergy conference

TechWorld Medicals was awarded “Best New Product” Wednesday evening at the ECRM Cough & Cold...

March 3, 2010
APhA recognizes Touro College with immunization award

The American Pharmacist Association has given its Immunization Champion Award to a school of pharmacy...

NEW YORK The American Pharmacist Association has given its Immunization Champion Award to a school of pharmacy in New York City.

 

Touro College of Pharmacy, in the Harlem neighborhood, was among more than 100 nominees competing for the ward, which receives support from Novartis Vaccines & Diagnostics. The award program will take place at the APhA’s annual meeting in Washington from March 12 to 15.

 

 

March 3, 2010
Bristol-Myers Squibb discusses pipeline with investors

Aims of becoming a leader in biotechnology headlined a meeting Thursday between Bristol-Myers Squibb and...

March 3, 2010
Shire given market exclusivity for ADHD drug

The U.S. District Court for the District of Columbia has upheld a decision by the...

March 3, 2010
To avoid dispensing errors, Takeda changes drug name

A drug made by Takeda Pharmaceuticals for treating heartburn is getting a name change, Takeda...

March 3, 2010
Watson to acquire rights of progesterone products from Columbia Labs

Watson Pharmaceuticals will buy the U.S. rights to two progesterone products used to treat infertility...

March 3, 2010
Whole grain diet may lower Type 2 diabetes risk, study finds

Lowering one's risk of developing Type 2 diabetes can be as simple as implementing whole...

March 2, 2010
CRN: No safety issues with fish oil

In response to a lawsuit filed Tuesday in California, which claimed that fish oil supplements...

March 2, 2010
dLife members show increased use of prescription drugs to treat diabetes

Users of a multimedia network for people with diabetes showed an increase in their use...

March 2, 2010
FDA issues complete response letter to Bristol-Myers Squibb

The Food and Drug Administration has declined to approve a biotech drug for organ transplant...

March 2, 2010
GPhA: GAO report highlights need for availability of biogenerics

An organization representing the generic drug industry is holding up a recent report by the...